| Literature DB >> 14643031 |
Taro Yokoyama1, Junji Sagara, Xin Guan, Junya Masumoto, Michiko Takeoka, Yuichi Komiyama, Kazunobu Miyata, Kayoko Higuchi, Shun'ichiro Taniguchi.
Abstract
ASC/TMS1, a proapoptotic activator of procaspase-1, was reported to be aberrantly methylated in human breast cancer. We found that ASC was methylated in three of five human colon cancer cell lines lacking ASC protein expression. Demethylation treatment of these cell lines lacking ASC with 5-aza-2'-deoxycytidine partially restored ASC expression. Methylated ASC was also detected in six of ten colorectal cancer tissues. Although clear down-regulation of ASC in the whole region of a tumor tissue was hardly observed by immunostaining with anti-ASC mAb, complete suppression of ASC was identified in a minor population of the colorectal tumor cells. The biological significance of ASC methylation inducible ASC suppression in colorectal cancer will be discussed.Entities:
Mesh:
Substances:
Year: 2003 PMID: 14643031 DOI: 10.1016/j.canlet.2003.08.027
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679